Materias dentro de su búsqueda.
Mostrando 621 - 640 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 0.51s Limitar resultados
  1. 621
    “…Thus, the material was procured before pancreatic cancer has developed, rather than from PanINs in a tissue field that already contains cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer
  2. 622
    “…However, little is known about their role in pancreatic cancer. The objective of this study was to clarify the clinical significance of the SWItch/sucrose nonfermentable (SWI/SNF) complex in patients with pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The clinical significance of SWI/SNF complex in pancreatic cancer
  3. 623
    “…This paper will focus on EUS-guided oncologic therapy for pancreatic cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Endoscopic Ultrasound-Guided Oncologic Therapy for Pancreatic Cancer
  4. 624
    “…Background: Genetic risk factors for sporadic pancreatic cancer are largely unknown but actually under high exposure. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Blood group determinates incidence for pancreatic cancer in Germany
  5. 625
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correction: Clusterin confers gemcitabine resistance in pancreatic cancer
  6. 626
    por Cappello, Paola, Novelli, Francesco
    Publicado 2013
    “…This approach provides a springboard for the elaboration of new forms of immunotherapy for pancreatic cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A self antigen reopens the games in pancreatic cancer
  7. 627
    “…BACKGROUND: Nab-paclitaxel and gemcitabine have demonstrated a survival benefit over gemcitabine alone in advanced pancreatic cancer (PDA). This study aimed to investigate the clinical, biological, and imaging effects of the regimen in patients with operable PDA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
  8. 628
    “…Palliative treatment concepts are considered in patients with non-curatively resectable and/or metastasized pancreatic cancer. However, patients without metastases, but presented with marginally resectable or locally non-resectable tumors should not be treated by a palliative therapeutic approach. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
  9. 629
    “…Evidence for the efficacy of targeted alpha therapy for the control of pancreatic cancer in preclinical models is reviewed. Results are given for in vitro pancreatic cancer cells and clusters and micro-metastatic cancer lesions in vivo. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Targeted Alpha Therapy Approach to the Management of Pancreatic Cancer
  10. 630
    “…Pancreatic cancer is one of the leading cancer-related causes of death in the western world with an urgent need for new treatment strategies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    In Vivo Activity and Pharmacokinetics of Nemorosone on Pancreatic Cancer Xenografts
  11. 631
    “…A clear contradiction exists between cytotoxic in-vitro studies demonstrating effectiveness of Gemcitabine to curtail pancreatic cancer and in-vivo studies failing to show Gemcitabine as an effective treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Predictive Modeling of In Vivo Response to Gemcitabine in Pancreatic Cancer
  12. 632
    “…To date, scientists have obtained a substantial amount of knowledge with regard to genes and microRNAs (miRNAs) in pancreatic cancer (PC). However, deciphering the regulatory mechanism of these genes and miRNAs remains difficult. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    microRNA and gene networks in human pancreatic cancer
  13. 633
    “…The low prevalence of pancreatic cancer remains an obstacle to the development of effective screening tools in an asymptomatic population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
  14. 634
    “…Today, neural invasion (NI) in pancreatic cancer (PCa) stands out due to the recent demonstration of its association with tumor progression, local recurrence and neuropathic pain. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neural Invasion in Pancreatic Cancer: The Past, Present and Future
  15. 635
    “…There is increasing evidence demonstrating that epithelial-mesenchymal transition (EMT) contributes to pancreatic cancer metastasis and to treatment resistance. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression
  16. 636
    por Verma, Mukesh
    Publicado 2010
    “…Pancreatic cancer is the fourth most common cause of cancer-related mortality in the United States. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology
  17. 637
    por Nakao, Akimasa
    Publicado 2010
    “…Pancreatic cancer has the worst prognosis of all gastrointestinal neoplasms. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
  18. 638
    “…For patients with unresectable pancreatic cancer, current chemotherapies have negligible survival benefits. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy of minimally invasive therapies on unresectable pancreatic cancer
  19. 639
    “…BACKGROUND: Pancreatic cancer is a deadly disease with a five-year survival of less than 5%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Integrative genomic and functional profiling of the pancreatic cancer genome
  20. 640
    por Ma, Ying, Ullrich, Stephen E
    Publicado 2013
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Intratumoral mast cells promote the growth of pancreatic cancer
Herramientas de búsqueda: RSS